Brexpiprazole CAS 913611-97-9 Ubunyulu > 99.0% (HPLC) API Factory

Inkcazelo emfutshane:

Igama leKhemikhali: Brexpiprazole

CAS: 913611-97-9

Ubunyulu: >99.0% (HPLC)

Imbonakalo: Umgubo weCrystalline oMhlophe okanye oMhlophe

Umgangatho ophezulu we-API, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-enye CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Iipropati zeMichiza:

Igama leMchiza	Brexpiprazole
Izithethantonye	OPC-34712;7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-enye
Inombolo yeCAS	913611-97-9
Inombolo yeCAT	RF-PI1982
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C25H27N3O2S
Ubunzima beMolekyuli	433.57
Ukuxinana	1.245±0.060 g/cm3
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo weCrystalline oMhlophe okanye oMhlophe
Ukuchongwa	Ngu-IR
RT	Ngaphantsi kwe-chirality kufuneka ihambelane
I-Chloride	Inika ukusabela kwekloridi
Amanzi	3.0%~4.5%
Indawo yokunyibilika	198.0 ~ 202.0℃
Intsalela kwi-Ignition	<0.20%
Iintsimbi ezinzima	≤10ppm
Izinto ezinxulumeneyo
Ukungacoceki komntu	<0.50%
Ukungcola ngokupheleleyo	<1.00%
EE	>99.0%
Ubunyulu / Indlela yokuHlalutya	>99.0% (HPLC, ngokomileyo)
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	API

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-Brexpiprazole (i-CAS: i-913611-97-9) ngumviwa weziyobisi oluncedo kunyango kunye nokuthintela ukuphazamiseka kwengqondo kuquka ukuphazamiseka kwe-CNS.I-Brexpiprazole lichiza eliyinoveli le-antipsychotic elisebenza njenge-serotonin ® dopamine umsebenzi wemodyuli kwaye ibonise ukusebenza njengonyango lokongezelela kwizigulana ezinoxinzelelo olukhulu loxinzelelo (MDD).I-Brexpiprazole ibonisa iphrofayili ekhethekileyo ye-pharmacological, esebenza njenge-agonist inxalenye ye-serotonin 5-HT1A kunye ne-dopamine D2 receptors kunye nomchasi opheleleyo we-5-HT2A kunye ne-noradrenaline α1B / 2C i-receptors, kunye ne-subnanomolar efanayo ebophelelayo.I-Brexpiprazole yaphuhliswa ngu-Otsuka kunye no-Lundbeck, yavunywa kwi-2015 yi-FDA yonyango lwe-schizophrenia kunye nonyango olongezelelweyo lokudakumba.I-Brexpiprazole ithathwa ngokubanzi njengendlalifa ye-Otsuka ye-antipsychotic drug aripiprazole (igama lorhwebo i-Abilify) eliphelelwe ilungelo labo lomenzi ngo-Agasti ka-2014.